These results indicate that different tumour lineages exhibit selective dependencies upon distinct BCL2 proteins for survival, with melanoma exhibiting a strong bias towards MCL1 and CRC an apparent bias towards BCL-XL. This evidence concerns the gene MCL1 and colorectal carcinoma.